Literature DB >> 32524303

To Study the Anti-cancer Effects of Shigella Flexneri in AspC-1 Pancreatic Cancer Cell Line in Approach to Bax and bcl-2 Genes.

Amir Khodavirdipour1,2, Fahimeh Jamshidi3, Hamideh Rouhani Nejad4, Masoud Zandi3, Rana Zarean5.   

Abstract

INTRODUCTION: Cancer is the uncontrolled division of cells and can be caused by genetic or environmental factors. Pancreatic cancer is one of the deadliest among all cancers. The role of bacteria as an anticancer agent dates back to almost 100 years ago. The microbiome has recently become a focus of research in carcinogenesis and even pancreatic cancer. Shigella flexneri is a gram-negative bacterium, which causes shigellosis with symptoms such as diarrhea, fever, and stomach cramps in human. Shigella flexneri may play a very important role in the internal pathways of apoptosis and may induce apoptosis in some of the cancerous cells.
MATERIAL AND METHODS: In this experiment bacteria were cultured on Salmonella-Shigella agar, then inoculated into BHI Broth medium. After sonication, the protein concentration of the bacterium was measured by using the ZellBio Sensitive Protein Bradford Assay kit. MTT assay was performed to obtain IC50 for the said bacterial protein. Later by cDNA kit synthesized the cDNA based on the RNA template. In the end, the results were analyzed using real-time PCR and the expression of Bax and Bcl-2 genes was measured before and after treatment.
RESULTS: The results showed that Shigella flexneri has the potential anti-proliferative effect in pancreatic cancer. The inhibitory concentration, pro-apoptotic amount to upregulate Bax, and meanwhile also to downregulate the bcl-2 found to be 10 μl.
CONCLUSION: In general, due to defects in the apoptotic pathway in cancer cells and the existence of drug-resistant cells, the detection of new apoptotic inducers such as Shigella flexneri cell extract can be used for further studies on cancer therapy.

Entities:  

Keywords:  Apoptosis; Cancer treatment; Chemotherapeutic agent; Pancreatic cancer; Real-time PCR; Shigella flexneri

Year:  2021        PMID: 32524303     DOI: 10.1007/s12029-020-00433-9

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  8 in total

Review 1.  Modulation of host cell apoptotic pathways by intracellular pathogens.

Authors:  Anja Friedrich; Julian Pechstein; Christian Berens; Anja Lührmann
Journal:  Curr Opin Microbiol       Date:  2017-03-19       Impact factor: 7.934

Review 2.  Functions of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system effectors.

Authors:  Rita Figueira; David W Holden
Journal:  Microbiology       Date:  2012-03-15       Impact factor: 2.777

Review 3.  Engineering the perfect (bacterial) cancer therapy.

Authors:  Neil S Forbes
Journal:  Nat Rev Cancer       Date:  2010-10-14       Impact factor: 60.716

4.  Microarray analysis of Shigella flexneri-infected epithelial cells identifies host factors important for apoptosis inhibition.

Authors:  Christina S Faherty; D Scott Merrell; Cristina Semino-Mora; Andre Dubois; Aishwarya V Ramaswamy; Anthony T Maurelli
Journal:  BMC Genomics       Date:  2010-04-29       Impact factor: 3.969

Review 5.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

Review 6.  Pancreas regeneration.

Authors:  Qiao Zhou; Douglas A Melton
Journal:  Nature       Date:  2018-05-16       Impact factor: 49.962

Review 7.  Human papillomavirus and gastrointestinal cancer in Iranian population: A systematic review and meta-analysis.

Authors:  Versa Omrani-Navai; Reza Alizadeh-Navaei; Yousef Yahyapour; Akbar Hedayatizadeh-Omran; Saeid Abediankenari; Ghasem Janbabaei; Fatima Toghani
Journal:  Caspian J Intern Med       Date:  2017

8.  Shigella type III secretion protein MxiI is recognized by Naip2 to induce Nlrc4 inflammasome activation independently of Pkcδ.

Authors:  Shiho Suzuki; Luigi Franchi; Yuan He; Raul Muñoz-Planillo; Hitomi Mimuro; Toshihiko Suzuki; Chihiro Sasakawa; Gabriel Núñez
Journal:  PLoS Pathog       Date:  2014-02-06       Impact factor: 6.823

  8 in total
  2 in total

1.  The Protective Mechanism of Afuresertib against Esophageal Cancer.

Authors:  Bo Min; Yan Wang; Feng Liang; Cheng-Xiang Wang; Fan Wang; Zhi Yang
Journal:  Dis Markers       Date:  2022-07-14       Impact factor: 3.464

Review 2.  An Exploration of Oral-Gut Pathogens Mediating Immune Escape of Pancreatic Cancer via miR-21/PTEN Axis.

Authors:  Rui Li; Yaoyuan Hu; Shuhong Hou
Journal:  Front Microbiol       Date:  2022-06-22       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.